Mutual funds holding both Gland Pharma and JB Chemicals & Pharmaceuticals

Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 11 mutual funds hold active equity positions in both Gland Pharma and JB Chemicals & Pharmaceuticals. The scheme with the highest combined exposure is Nippon India Pharma Fund (Nippon India MF), which holds a 4.08% stake in Gland Pharma and a 3.70% stake in JB Chemicals & Pharmaceuticals, amounting to a combined conviction weight of 7.78%.

When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.